Business context and reporting period
This is Dr Pepper Snapple Group, Inc.’s unaudited Form 10-Q for the quarter ended June 30, 2015, with six-month comparisons to 2014. The filing is not in the name of Keurig Dr Pepper Inc.; the company’s 2015 reporting name was Dr Pepper Snapple Group. Its three segments are Beverage Concentrates, Packaged Beverages, and Latin America Beverages.
Key financial metrics
| Metric | Q2 2015 | Q2 2014 | Six months 2015 | Six months 2014 |
|---|---|---|---|---|
| Net sales | $1.655bn | $1.631bn | $3.106bn | $3.029bn |
| Gross profit | $981m | $966m | $1.830bn | $1.810bn |
| Gross margin | 59.3% | 59.2% | 58.9% | 59.8% |
| Operating income | $369m | $348m | $639m | $608m |
| Net income | $220m | $210m | $377m | $365m |
| Diluted EPS | $1.14 | $1.06 | $1.95 | $1.84 |
| Operating cash flow | Not presented for quarter | $349m | $438m |
For the six months, SG&A was $1.138bn versus $1.146bn, and the effective tax rate was 35.6% versus 34.8%. Capital expenditures were $42m. Cash and equivalents were $127m at June 30, down from $237m at year-end 2014.
Debt, liquidity, and capital returns
Debt obligations totaled $2.602bn at June 30, including $505m classified as current, principally the $500m 2.90% notes due January 15, 2016. Long-term obligations were $2.097bn. The company had no commercial paper outstanding at quarter-end and $499m available under its $500m revolving credit facility; it reported compliance with financial covenants. Management said it intends to issue senior notes to refinance the 2016 notes and believes operating cash flows will cover anticipated obligations for the next 12 months.
Six-month financing cash outflows were $409m, including $251m of share repurchases and $172m of dividends paid. Dividends declared were $0.96 per share for the first half. The board’s repurchase authorization had $921m remaining at June 30.
Material changes and management commentary
- Q2 sales rose 1%, while net income increased 5% and diluted EPS increased 8%. Six-month sales rose 3%, operating income 5%, and net income 3%.
- Six-month volume (BCS) rose 2%. Packaged Beverages sales increased 4% for the first half and segment operating profit rose 7%; Beverage Concentrates sales increased 1% and segment profit rose 4%. Latin America sales declined 4% in dollars despite 10% volume growth, largely reflecting unfavorable currency translation.
- Foreign currency translation reduced sales by $29m in Q2 and $47m for the first half. Management attributed first-half sales growth to branded volume, favorable product/package mix, and segment mix.
- First-half gross margin declined to 58.9% from 59.8%, reflecting unfavorable product, package and segment mix, commodity-derivative mark-to-market comparisons, and currency effects, partly offset by productivity and lower commodity costs. Q2 gross margin was slightly higher year over year.
- Operating cash flow fell $89m year over year, primarily due to working-capital changes. Management expects 2015 capital expenditures, net of disposals, to be approximately 3% of net sales, funded from operating cash flow.
Outlook, risks, contingencies, and unusual items
The filing provides no specific earnings or revenue guidance. Management noted beverage sales seasonality, with sales generally higher in warmer months, and identified continued capital spending, dividends, repurchases, commercial-paper access, and refinancing the 2016 notes as liquidity considerations.
Risks include foreign-exchange, interest-rate, and commodity-price movements; management estimated a 10% currency-rate change could affect annual operating income by approximately $23m. Unhedged commodity-price movements could affect remaining-2015 operating income by approximately $5m for a 10% change. Commodity derivatives had a net fair-value liability of $22m. The company reported no material change in its previously disclosed risk factors.
The company did not expect pending legal matters to have a material adverse effect. A New Jersey Superfund site investigation remains unresolved; costs have not been reasonably estimable, and the company had paid approximately $750,000 through June 30 toward its allocated study costs. First-half gross profit included a $3m benefit from LIFO inventory liquidation. No goodwill or indefinite-lived intangible impairment indicators were identified at quarter-end.
Important facts for investors to verify
- Confirm the filing entity and reporting period: Dr Pepper Snapple Group, Inc., quarter ended June 30, 2015.
- Review the $500m January 2016 maturity and the company’s planned refinancing progress.
- Assess the working-capital-related decline in operating cash flow alongside shareholder returns and planned capital spending.
- Track currency and product-mix impacts, particularly in Latin America, and the durability of volume growth and margin performance.
- Monitor commodity-hedge results, the New Jersey environmental matter, and any subsequent updates to outlook or contingencies.